Study led by Manitoba doctor shows promising treatment for COVID-19 patients
A global trial led by Winnipeg and Canadian researchers is showing promising results in treating some COVID-19 cases.
Dr. Ryan Zarychanski’s study on blood thinners in COVID positive patients was published Wednesday in the New England Journal of Medicine.
The study found that treating some hospitalized patients with blood thinners increases their chance of survival and reduces their need for intensive care.
"A blood thinner drug that has anti-inflammatory and antiviral properties has been shown in our large global trial to increase survival without the need for ICU-level care," said Zarychanski.
That drug is heparin, an inexpensive and widely available medication used to treat blood clots. Blood clots and inflammation were noted early on in the pandemic as serious complications of COVID-19.
“For us to demonstrate that a drug that is incredibly inexpensive, widely available around the world and familiar to doctors all over the globe, for us to demonstrate that this drug could be used too, and can save lives and reduce the burden of critical illness on health-care systems is a huge win,” said Zarychanski.
The findings could impact patient care immediately, with Zarychanski saying physicians within organized health-care systems could start using heparin molecules to treat patients admitted to hospital with the virus, but who are not yet critically ill.
"We think it will reduce the burden of critical illness due to COVID-19 by approximately 25 per cent when used in health systems that adopt that therapy," said Zarychanski.
While results in December of 2020 showed no benefits to those already critically ill, the researchers say it could be a key tool in saving the lives of non-critically ill patients by knowing who to target.
The study was also the first of its kind, a clinical trial on a global scale during a pandemic. Zarychanski said the methods developed during the study will change how researchers approach large-scale clinical trials in the future.
“We developed methods that allowed independent platforms, so independent research entities can still maintain their independence but work collaboratively,” said Zarychanski.
The trial spanned five continents and involved patients from 300 hospitals.
CTVNews.ca Top Stories
'Still so much love between us,' Sophie Gregoire Trudeau says of Prime Minister Justin Trudeau
Sophie Gregoire Trudeau says there is 'still so much love' between her and Prime Minister Justin Trudeau, as they navigate their post-separation relationship co-parenting their three children.
What to know about avian influenza in dairy cows and the risk to humans
Why is H5N1, or bird flu, a concern, how does it spread, and is there a vaccine? Here are the answers to some frequently asked questions about avian influenza.
'I was scared': Ontario man's car repossessed after missing two repair loan payments
An Ontario man who took out a loan to pay for auto repairs said his car was repossessed after he missed two payments.
opinion The special relationship between King Charles and the Princess of Wales
Royal commentator Afua Hagan writes that when King Charles recently admitted Catherine to the Order of the Companions of Honour, it not only made history, but it reinforced the strong bond between the King and his beloved daughter-in-law.
Pro-plastic lobbyist presence at UN talks is 'troubling,' say advocates
Environmentalist groups are sounding the alarm about a steep increase in the number of pro-plastic lobbyists at the UN pollution talks taking place this week.
'Too young to have breast cancer': Rates among young Canadian women rising
Breast cancer rates are rising in Canada among women in their 20s, 30s and 40s, according to research by the University of Ottawa (uOttawa).
Charlie Woods, son of Tiger, shoots 81 in U.S. Open qualifier
Charlie Woods failed to advance in a U.S. Open local qualifying event Thursday, shooting a 9-over 81 at Legacy Golf & Tennis Club.
$70M Lotto Max winners kept prize a secret from family for 2 months
During a special winner celebration near their hometown, Doug and Enid shared the story of how they discovered they were holding a Lotto Max ticket worth $70 million and how they kept this huge secret for so long.
Courteney Cox says her partner Johnny McDaid once broke up with her in therapy
Courteney Cox's longtime partner Johnny McDaid once broke up with her in a therapy session.